The Evolution of Musculoskeletal Tumor Imaging

Radiologic Clinics of North America

Volumn 47, Issue 3, 2009, Pages 435-453

  Hwang, Sinchun ^a   Panicek, David M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Angiography; Bone tumor; CT; History; MR imaging; Nuclear medicine; Radiography; Radiology; Soft tissue tumor; Ultrasound

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; MEDRONATE TECHNETIUM TC 99M; TECHNETIUM 99M; THALLIUM 201;

BONE METASTASIS; BONE TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; EWING SARCOMA; FEMUR; HEMANGIOMA; HUMAN; MOLECULAR IMAGING; MUSCLE TUMOR; MYXOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; OSSIFICATION; OSTEOSARCOMA; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; SOFT TISSUE CALCIFICATION; ULTRASOUND;

ANGIOGRAPHY; BONE NEOPLASMS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MUSCLE NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 63649112362     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2008.12.002     Document Type: Review

References (69)

1. Zantinga A.R., and Coppes M.J. James Ewing (1866-1943): "the chief". Med Pediatr Oncol 21 7 (1993) 505-510
2. McCarthy E.F. The registry of bone sarcoma: a history. Iowa Orthop J 15 (1995) 74-78
3. Lodwick G.S. A probabilistic approach to the diagnosis of bone tumors. Radiol Clin North Am 3 3 (1965) 487-497
4. Madewell J.E., Ragsdale B.D., and Sweet D.E. Radiologic and pathologic analysis of solitary bone lesions. Part I: internal margins. Radiol Clin North Am 19 4 (1981) 715-748
5. Edeiken J., Hodes P.J., and Caplan L.H. New bone production and periosteal reaction. Am J Roentgenol Radium Ther Nucl Med 97 3 (1966) 708-718
6. Erlemann R., Sciuk J., Bosse A., et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 175 3 (1990) 791-796
7. Smith J., Heelan R.T., Huvos A.G., et al. Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients. Radiology 143 2 (1982) 355-360
8. Ackerman L.V. Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans): clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg Am 40-A 2 (1958) 279-298
9. McCurley J.M. The contribution of fundamental discovery to the emergence of nuclear medicine as a discipline. Radiographics 15 5 (1995) 1243-1259
10. Bekerman C., Hoffer P.B., and Bitran J.D. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 14 4 (1984) 296-323
11. Subramanian G., McAfee J.G., Blair R.J., et al. Technetium-99m-methylene diphosphonate-a superior agent for skeletal imaging: comparison with other technetium complexes. J Nucl Med 16 8 (1975) 744-755
12. Cook G.J., and Fogelman I. The role of nuclear medicine in monitoring treatment in skeletal malignancy. Semin Nucl Med 31 3 (2001) 206-211
13. Pollen J.J., Witztum K.F., and Ashburn W.L. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. AJR Am J Roentgenol 142 4 (1984) 773-776
14. Lemieux J., Guimond J., Laberge F., et al. The bone scan flare phenomenon in non-small-cell lung cancer. Clin Nucl Med 27 7 (2002) 486-489
15. Coleman R.E., Mashiter G., Whitaker K.B., et al. Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 29 8 (1988) 1354-1359
16. Kostakoglu L., Panicek D.M., Divgi C.R., et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med 22 11 (1995) 1232-1237
17. Sumiya H., Taki J., Tsuchiya H., et al. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors. Nucl Med 39 9 (1998) 1600-1604
18. Ter-Pogossian M.M., Phelps M.E., Hoffman E.J., et al. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology 114 1 (1975) 89-98
19. Gallagher B.M., Ansari A., Atkins H., et al. Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 18 10 (1977) 990-996
20. Rohren E.M., Turkington T.G., and Coleman R.E. Clinical applications of PET in oncology. Radiology 231 2 (2004) 305-332
21. Beyer T., Townsend D.W., Brun T., et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 41 8 (2000) 1369-1379
22. Schmidt G.P., Haug A.R., Schoenberg S.O., et al. Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol 16 6 (2006) 1216-1225
23. Toner G.C., and Hicks R.J. PET for sarcomas other than gastrointestinal stromal tumors. Oncologist 13 Suppl 2 (2008) 22-26
24. Folpe A.L., Lyles R.H., Sprouse J.T., et al. (F-18) Fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 6 (2000) 1279-1287
25. Franzius C., Sciuk J., Daldrup-Link H.E., et al. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 27 9 (2000) 1305-1311
26. Hudson T.M., Enneking W.F., and Hawkins Jr. I.F. The value of angiography in planning surgical treatment of bone tumors. Radiology 138 2 (1981) 283-292
27. Levine E., De Smet A.A., and Neff J.R. Role of radiologic imaging in management planning of giant cell tumor of bone. Skeletal Radiol 12 2 (1984) 79-89
28. Feydy A., Anract P., Tomeno B., et al. Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast-enhanced MR angiography. Radiology 238 2 (2006) 611-621
29. McLean G., and Freiman D.B. Angiography of skeletal disease. Orthop Clin North Am 14 1 (1983) 257-270
30. Newman P.G., and Rozycki G.S. The history of ultrasound. Surg Clin North Am 78 2 (1998) 179-195
31. Hounsfield G.N. Computed medical imaging. Nobel lecture, December 8, 1979. J Comput Assist Tomogr 4 5 (1980) 665-674
32. Kalender W.A., Seissler W., Klotz E., et al. Spiral volumetric CT with single-breath-hold technique, continuous transport, and continuous scanner rotation. Radiology 176 1 (1990) 181-183
33. Heelan R.T., Watson R.C., and Smith J. Computed tomography of lower extremity tumors. AJR Am J Roentgenol 132 6 (1979) 933-937
34. Mercuri M., Capanna R., Manfrini M., et al. The management of malignant bone tumors in children and adolescents. Clin Orthop Relat Res 264 (1991) 156-168
35. Schreiman J.S., Crass J.R., Wick M.R., et al. Osteosarcoma: role of CT in limb-sparing treatment. Radiology 161 2 (1986) 485-488
36. Panicek D.M., Gatsonis C., Rosenthal D.I., et al. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: report of the Radiology Diagnostic Oncology Group. Radiology 202 1 (1997) 237-246
37. Assoun J., Richardi G., Railhac J.J., et al. Osteoid osteoma: MR imaging versus CT. Radiology 191 1 (1994) 217-223
38. Davies A.M., Cassar-Pullicino V.N., and Grimer R.J. The incidence and significance of fluid-fluid levels on computed tomography of osseous lesions. Br J Radiol 65 771 (1992) 193-198
39. Richardson M.L., Amparo E.G., Gillespy III T., et al. Theoretical considerations for optimizing intensity differences between primary musculoskeletal tumors and normal tissue with spin-echo magnetic resonance imaging. Invest Radiol 20 5 (1985) 492-497
40. Claussen C., Laniado M., Schörner W., et al. Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. AJNR Am J Neuroradiol 6 5 (1985) 669-674
41. Erlemann R., Reiser M.F., Peters P.E., et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 171 3 (1989) 767-773
42. Kroon H.M., Bloem J.L., Holscher H.C., et al. MR imaging of edema accompanying benign and malignant bone tumors. Skeletal Radiol 23 4 (1994) 261-269
43. Schweitzer M.E., Levine C., Mitchell D.G., et al. Bull's-eyes and halos: useful MR discriminators of osseous metastases. Radiology 188 1 (1993) 249-252
44. Kaim A.H., Hügli R., Bonél H.M., et al. Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation. Skeletal Radiol 31 2 (2002) 88-95
45. James S.L., Hughes R.J., Ali K.E., et al. MRI of bone marrow oedema associated with focal bone lesions. Clin Radiol 61 12 (2006) 1003-1009
46. James S.L., Panicek D.M., and Davies A.M. Bone marrow oedema associated with benign and malignant bone tumours. Eur J Radiol 67 1 (2008) 11-21
47. Van Dyck P., Vanhoenacker F.M., Vogel J., et al. Prevalence, extension and characteristics of fluid-fluid levels in bone and soft tissue tumors. Eur Radiol 16 12 (2006) 2644-2651
48. Simpfendorfer C.S., Ilaslan H., Davies A.M., et al. Does the presence of focal normal marrow fat signal within a tumor on MRI exclude malignancy? An analysis of 184 histologically proven tumors of the pelvic and appendicular skeleton. Skeletal Radiol 37 9 (2008) 797-804
49. Panicek D.M., Lautin J.L., Schwartz L.H., et al. Non-Hodgkin lymphoma in skeletal muscle manifesting as homogeneous masses with CT attenuation similar to muscle. Skeletal Radiol 26 11 (1997) 633-635
50. Sundaram M., McGuire M.H., Herbold D.R., et al. High signal intensity soft tissue masses on T1-weighted pulsing sequences. Skeletal Radiol 16 1 (1987) 30-36
51. Jelinek J.S., Kransdorf M.J., Shmookler B.M., et al. Giant cell tumor of the tendon sheath: MR findings in nine cases. AJR Am J Roentgenol 162 4 (1994) 919-922
52. Sundaram M., McGuire M.H., and Schajowicz F. Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. AJR Am J Roentgenol 148 6 (1987) 1247-1250
53. Wu J.S., Goldsmith J.D., Horwich P.J., et al. Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy?. Radiology 248 3 (2008) 962-970
54. Genant J.W., Vandevenne J.E., Bergman A.G., et al. Interventional musculoskeletal procedures performed by using MR imaging guidance with a vertically open MR unit: assessment of techniques and applicability. Radiology 223 1 (2002) 127-136
55. Meyers P.A., Gorlick R., Heller G., et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 16 7 (1988) 2452-2458
56. Dyke J.P., Panicek D.M., Healey J.H., et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 228 1 (2003) 271-278
57. Karchevsky M., Babb J.S., and Schweitzer M.E. Can diffusion-weighted imaging be used to differentiate benign from pathologic fractures? A meta-analysis. Skeletal Radiol 37 9 (2008) 791-795
58. Herneth A.M., Ringl H., Memarsadeghi M., et al. Diffusion weighted imaging in osteoradiology. Top Magn Reson Imaging 18 3 (2007) 203-212
59. Hayashida Y., Yakushiji T., Awai K., et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 16 (2006) 2637-2643
60. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 2 (2001) 316-333
61. Wolbarst A.B., and Hendee W.R. Evolving and experimental technologies in medical imaging. Radiology 238 1 (2006) 16-39
62. Wang C.K., Li C.W., Hsieh T.J., et al. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology 232 2 (2004) 599-605
63. Fayad L.M., Barker P.B., Jacobs M.A., et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol 188 (2007) 1513-1520
64. Fayad L.M., Bluemke D.A., McCarthy E.F., et al. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 23 (2006) 23-28
65. Sah P.L., Sharma R., Kandpal H., et al. In vivo proton spectroscopy of giant cell tumor of the bone. AJR Am J Roentgenol 190 (2008) W133-W139
66. Steen R.G. Characterization of tumor hypoxia by 31P MR spectroscopy. AJR Am J Roentgenol 157 2 (1991) 243-248
67. Matsumoto S., Hyodo F., Subramanian S., et al. Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice. J Clin Invest 118 5 (2008) 1965-1973
68. Gallez B., Baudelet C., and Jordan B.F. Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. NMR Biomed 17 5 (2004) 240-262
69. Grönroos T., and Minn H. Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology. Eur J Nucl Med Mol Imaging 34 10 (2007) 1563-1565